This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Noa Therapeutics

Profile

At Noa Therapeutics, we are passionately committed to transforming the treatments of complex immune diseases. We are driven by an intimate understanding of the disappointments and complications that patients face, again and again with current treatment options. We aim to defy this convention, seeing complexity as an opportunity for innovation. We are committed to the development of therapeutics that patients want and need. We envision a future where patients break free of the cycle of treatment failures, where therapeutics provide a return to a high quality of life. We aim to deliver medications for all patients, irrespective of their stage of life or severity of their condition. We aim to delivery disease modification, putting an end to the chronic cycle of current treatment failures.We strive to authentically represents the diverse populations we serve. Our dedication to patients involves offering therapeutics that address previously excluded, underserved, and underrepresented patient populations. Our dedication to our community involves providing growth opportunities and a guiding framework for meaningful innovation. Our dedication drives meaningful change, creating a better future for all. At Noa Therapeutics, we are committed to being a therapeutic company that listens to the real needs of patients. Our mission is not just about business; it's about making a profound impact on the lives we touch, now and for generations to come.